The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Diabetes Mellitus and the Risk of Cancer: Results From a Large-Scale Population-Based Cohort Study in Japan
Abstract
BACKGROUND: An association between diabetes mellitus (DM) and cancer has long been speculated, but no conclusive evidence has been obtained. METHODS: We prospectively examined the association between a history of DM and subsequent risk of cancer in the Japan Public Health Center-Based Prospective Study. A total of 97 771 general Japanese persons (46 548 men and 51 223 women) aged 40 to 69 years who responded to the baseline questionnaire, from January 1990 to December 1994, were followed up for cancer incidence through December 31, 2003. At baseline, 6.7% of men and 3.1% of women had a history of DM. RESULTS: A total of 6462 cases of newly diagnosed cancer were identified. In men, a 27% increase in the risk of total cancer incidence was observed in those with a history of DM (n = 3907 [366 with DM]; hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.14-1.42). The HR was especially high for those with cancer of the liver (n = 312 [52 with DM]; HR, 2.24; 95% CI, 1.64-3.04), pancreas (n = 118 [16 with DM]; HR, 1.85; 95% CI, 1.07-3.20), and kidney (n = 99 [13 with DM]; HR, 1.92; 95% CI, 1.06-3.46). We also observed a moderately increased risk of colon cancer (n = 491 [46 with DM]; HR, 1.36; 95% CI, 1.00-1.85) and of stomach cancer with borderline significance (n = 977 [87 with DM]; HR, 1.23; 95% CI, 0.98-1.54). In women, a borderline significant increase in risk was observed for the incidence of total cancer (n = 2555 [104 with DM]; HR, 1.21; 95% CI, 0.99-1.47), while statistical significance was observed for the incidence of stomach cancer (n = 362 [20 with DM]; HR, 1.61; 95% CI, 1.02-2.54) and liver cancer (n = 120 [10 with DM]; HR, 1.94; 95% CI, 1.00-3.73) and borderline significance was observed for the incidence of ovarian cancer (n = 74 [5 with DM]; HR, 2.42; 95% CI, 0.96-6.09). CONCLUSION: Patients with DM drawn from the general Japanese population may be at increased risk of total cancer and of cancer in specific sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The underlying mechanisms of tumorigenesis in T2DM seem to be related to insulin resistance, hyperinsulinemia, elevated levels of IGF-1 [140-142], and hyperglycemia with the latter driving ATP production in cancer cells through the glycolytic pathway, a mechanism known as the Warburg effect [142].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [140]
Citations
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,294
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 989
Le Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 848
Giovannucci, E. L. (1995) · Cancer Causes & Control · doi:10.1007/bf00052777 · Cited by 808
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J. M., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 562
Xu, S., Zhang, G., Guan, F., Dong, D., Luo, L., Li, B., Ma, X., Zhao, J., & Sun, L. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0631-5 · Cited by 20
Othman, N. H., Nor, Z. M., & Biswal, B. M. (2008) · PubMed · Cited by 20
Shen, T., Chung, W., Lin, C., Wei, C., Chen, C., Chen, H.-J., Tu, C., Hsia, T., Shih, C., Hsu, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098290 · Cited by 19
Paraoxonase-1 and arylesterase activities in patients with colorectal cancer.
Afşar, Ç. U., Günaldı, M., Okuturlar, Y., Gedikbaşı, A., Tiken, E. E., Kahraman, S., Karaca, F., Erçolak, V., & Karabulut, M. (2015) · PubMed Central · Cited by 19
Cho, W.-R., Wang, C., Tsai, M., Chou, C., Liu, Y., Wu, Y., Lin, M., Chen, K., Chuang, C., Huang, P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247231 · Cited by 20
Gigoux, V., & Fourmy, D. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00050 · Cited by 20
Glargine safety, diabetes and cancer
Rendell, M., Aktürk, H. K., & Tella, S. H. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.770469 · Cited by 18
Incretin-mimetic therapies and pancreatic disease: a review of observational data
Suarez, E. A., Koro, C. E., Christian, J. B., Spector, A., de Araújo, A. B., & Abraham, S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.960515 · Cited by 19
Gastric carcinogenesis by N‐Methyl‐N‐Nitrosourea is enhanced in db/db diabetic mice
Yoshizawa, N., YAMAGUCHI, H., Yamamoto, M., Shimizu, N., Furihata, C., Tatematsu, M., Seto, Y., & Kaminishi, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01157.x · Cited by 18
Ahlquist, D. A. (2012) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000133 · Cited by 18
Association Between Diabetes and the Risk of Kidney Cancer: Systematic Review and Meta-Analysis
Bonilla-Sanchez, A., Rojas-Munoz, J., & García‐Perdomo, H. A. (2022) · Clinical Diabetes · doi:10.2337/cd21-0013 · Cited by 17
Diabetes Mellitus and Oral Cancer: A Retrospective Study from Austria
Remschmidt, B., Pau, M., Gaessler, J., Zemann, W., Jakse, N., Payer, M., & Végh, D. (2022) · Anticancer Research · doi:10.21873/anticanres.15666 · Cited by 17
Metabolic syndrome is associated with gastric dysplasia
Kim, N. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328349aa18 · Cited by 17
Glycemic Status and Prognosis of Patients with Squamous Cell Carcinoma of the Esophagus
Okamura, A., Watanabe, M., Imamura, Y., Hayami, M., Yamashita, K., Kurogochi, T., & Mine, S. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-4036-1 · Cited by 17
Yasutake, K., Bekki, M., Ichinose, M., Ikemoto, M., Fujino, T., Ryu, T., Wada, Y., Takami, Y., Saitsu, H., Kohjima, M., et al. (2012) · PubMed · Cited by 16
Lin, C., Cai, X., Yang, W., Lv, F., Nie, L., & Ji, L. (2020) · Endocrine · doi:10.1007/s12020-020-02376-4 · Cited by 16
Diabetes, colorectal cancer and cyclooxygenase 2 inhibition
Smith, C., McKay, G., & Fisher, M. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01726.x · Cited by 16
Chen, H.-F., Chang, Y., Ko, M.-C., & Li, C. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.001 · Cited by 16
Power, R. F., Doherty, D. E., Parker, I., Gallagher, D. J., Lowery, M. A., & Cadoo, K. A. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00196 · Cited by 16
Insulin resistance and hepatocarcinogenesis
Sasaki, Y. (2010) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-010-0177-6 · Cited by 15
Fukushima, H., Masuda, H., Kawakami, S., Ito, M., Sakura, M., Numao, N., Koga, F., Saito, K., Fujii, Y., Yamamoto, S., et al. (2012) · Urology · doi:10.1016/j.urology.2012.01.070 · Cited by 15
Li, Z., Luo, Y., Gong, Y., Liu, Y., Qiu, W., & Tu, J. (2011) · PubMed · Cited by 15
Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy
Chen, X., Chen, Y., Li, T., Jun, L., Lin, T., Huang, H., Huang, H., Liu, H., Liu, H., Li, G., et al. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.05.08 · Cited by 15
Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer
Kushchayeva, Y. S., Kushchayev, S. V., Jensen, K. E., & Brown, R. J. (2022) · Cancers · doi:10.3390/cancers14030555 · Cited by 19
Charles, T., Lindner, V., Matau, A., Roy, C., & Lang, H. (2010) · Annales d Urologie · doi:10.1016/s1762-0953(10)52713-4 · Cited by 15
Risk of Colorectal Cancer in Type 2 Diabetic Patients: A Population-based Cohort Study
Wang, J., Chao, T., Lai, C., Wang, C.-Y., Wu, V., Wang, S.-M., Lin, H.-I., Tang, S., & Lin, H. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys228 · Cited by 14
Al-Keilani, M. S., Alsmadi, D. H., Darweesh, R. S., & Alzoubi, K. H. (2018) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s153780 · Cited by 14
The relationship between glucose metabolism disorders and malignant thyroid disease
Duran, A. O., Anıl, C., Gürsoy, A., Nar, A., Altundağ, Ö., & Tütüncü, N. B. (2012) · International Journal of Clinical Oncology · doi:10.1007/s10147-012-0435-3 · Cited by 14
Zhu, R. C., Rattanakorn, K., Pham, S., Mallam, D., McIntyre, T. P., Salifu, M. O., Youssef, I., McFarlane, S. I., & Vignesh, S. (2017) · Colorectal Cancer · doi:10.2217/crc-2017-0001 · Cited by 14
Liao, K., Chuang, H., & Lai, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00765 · Cited by 14
Diabetes mellitus and colorectal carcinoma outcomes: a meta-analysis
Becker, D. J., Iyengar, A., Punekar, S. R., Kaakour, D., Griffin, M., Nicholson, J., & Gold, H. T. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03666-z · Cited by 14
la Torre, K. D., Song, M., Abe, S. K., Rahman, M. S., Islam, M. R., Saito, E., Min, S., Huang, D., Chen, Y., Gupta, P. C., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13561 · Cited by 12
Self-citationTanaka, H., Ihana‐Sugiyama, N., Sugiyama, T., & Ohsugi, M. (2018) · Journal of Epidemiology · doi:10.2188/jea.je20170155 · Cited by 13
[Cross-talk between insulin signaling and cell proliferation pathways].
Burnol, A.-F., Morzyglod, L., & Popineau, L. (2013) · Annales d'Endocrinologie · doi:10.1016/j.ando.2013.02.003 · Cited by 13
Risk prediction models for hepatocellular carcinoma in different populations
Ma, X., Yang, Y., Tu, H., Gao, J., Tan, Y.-T., Zheng, J.-L., Bray, F., & Xiang, Y.-B. (2016) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2016.02.02 · Cited by 13
Inverse relationship between insulin receptor expression and progression in renal cell carcinoma
Takahashi, M., Inoue, T., Huang, M., Numakura, K., Tsuruta, H., Saito, M., Maeno, A., Nakamura, E., Narita, S., Tsuchiya, N., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5552 · Cited by 13
Maskarinec, G., Fontaine, A., Torfadottir, J. E., Lipscombe, L. L., Lega, I. C., Figueroa, J. D., & Wild, S. H. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.02.005 · Cited by 13
Wu, H., Zhang, J.-J., & Zhou, B. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02415-6 · Cited by 12
Lee, E. K., Koo, B.-K., Hwangbo, Y., Lee, Y. J., Baek, J. Y., Jun, Y., Kim, S. Y., Sim, S. H., Lee, K. S., Park, I. H., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108751 · Cited by 13
Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer
Armando Rojas, R., Lindner, C., Schneider, I., González, I., Araya, H., Morales, E., Gómez, M., Nelson Urdaneta, L., Araya, P., & Morales, M. A. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i12.1997 · Cited by 12
Association between diabetes or antidiabetic therapy and lung cancer: A meta‐analysis
Wang, Z., Bao, C., Su, C., Xu, W., Luo, H., Chen, L., & Qi, X. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12112 · Cited by 12
Seixas, A. A., Gyamfi, L., Newsome, V., Ranger-Murdock, G., Butler, M. J., Rosenthal, D. M., Zizi, F., Youssef, I., McFarlane, S., & Jean‐Louis, G. (2018) · Cancer Management and Research · doi:10.2147/cmar.s177428 · Cited by 11
Corrao, S., Natoli, G., Nobili, A., Mannucci, P. M., Perticone, F., Arcoraci, V., & Argano, C. (2022) · Healthcare · doi:10.3390/healthcare10081459 · Cited by 12
The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
Gallagher, E. J., Novosyadlyy, R., Yakar, S., & LeRoith, D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_36 · Cited by 12
Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis
Nakamura, A., Yoneda, M., Fujita, K., Tajima, K., Kikuchi, K., Nakajima, A., Maeda, S., & Terauchi, Y. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00134.x · Cited by 12
Yamauchi, T., Inagaki, M., Yonemoto, N., Iwasaki, M., Akechi, T., Sawada, N., Iso, H., Noda, M., & Tsugane, S. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.11.008 · Cited by 11
Diabetes and Cancer: Epidemiological, Clinical, and Experimental Perspectives
Tseng, C., Chen, C., & Landolph, J. R. (2012) · Experimental Diabetes Research · doi:10.1155/2012/101802 · Cited by 13
Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient
Bell, D. S. H. (2015) · Case Reports in Endocrinology · doi:10.1155/2015/676191 · Cited by 11
Harding, J. L., Söderberg, S., Shaw, J. E., Zimmet, P., Pauvaday, V., Kowlessur, S., Tuomilehto, J., Alberti, K. G. M. M., & Magliano, D. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27503 · Cited by 11
Nakagawa, T., Kobayashi, T., Nishiumi, S., Hidaka, A., Yamaji, T., Sawada, N., Hirata, Y., Yamanaka, K., Azuma, T., Goto, A., et al. (2018) · Cancer Science · doi:10.1111/cas.13573 · Cited by 11
Self-citationSpoerl, S., Gerken, M., Schimnitz, S., Taxis, J., Fischer, R., Lindner, S. R., Ettl, T., Ludwig, N., Spoerl, S., Reichert, T. E., et al. (2022) · Current Oncology · doi:10.3390/curroncol29120758 · Cited by 11
Inoue, M. (2010) · Journal of Epidemiology · doi:10.2188/jea.je20090209 · Cited by 11
Self-citationCancer Chemopreventive and Therapeutic Potential of Guggulsterone
Almazari, I., & Surh, Y. (2012) · Topics in current chemistry · doi:10.1007/128_2012_344 · Cited by 11
Chen, H.-F., Chen, S.-W., Chang, Y., & Li, C. (2015) · Medicine · doi:10.1097/md.0000000000001494 · Cited by 11
Cancer risk in patients with diabetic nephropathy
Cheung, C. Y., Ma, M. K. M., Chak, W.-L., & Tang, S. C. W. (2017) · Medicine · doi:10.1097/md.0000000000008077 · Cited by 11
Lu, S., Sun, X., Zhang, W., Li, X., Zhou, Z., Xiao, R., Lv, Q., Tang, H., Wang, B., Qu, J., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106074 · Cited by 10
Sikdar, K. C., Walsh, S. J., Roche, M. M., Jiang, Y., Syrowatka, A., & Collins, K. D. (2013) · Canadian Journal of Public Health · doi:10.1007/bf03405668 · Cited by 10
Golubnitschaja, O. (2012) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-4602-2_14 · Cited by 10
Early detection of hepatocellular carcinoma in patients with diabetes mellitus
Nouso, K., Furubayashi, Y., Shiota, S., Miyake, N., Oonishi, A., Wakuta, A., Kariyama, K., Hiraoka, A., Tsuji, K., Itobayashi, E., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001638 · Cited by 10
Diabetes History and Gastric Cancer Risk: Different Results by Types of Follow-Up Studies
Bae, J. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.5.1523 · Cited by 10
Campbell, P. T., Newton, C. C., Jacobs, E. J., McCullough, M. L., Wang, Y., Rees‐Punia, E., Guinter, M. A., Murphy, N., Koshiol, J. E., Dehal, A. N., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0082 · Cited by 10
Park, J., Hong, J. Y., Han, K., & Shen, J. J. (2022) · Diabetes Care · doi:10.2337/dc22-0961 · Cited by 10
Zhang, L., Guan, L., Tang, X., & Zhao, Y. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s433412 · Cited by 10
Chen, J., Chiou, W., Chou, W.-Y., & Lin, J. (2013) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12084 · Cited by 10
Lin, C., Chiang, J.-H., Li, C.-I., Hsieh, T.-F., Liu, C.-S., Lin, W.-Y., Lee, Y. D., & Li, T.-C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.525 · Cited by 10
Is Diabetes a Risk Factor for Colorectal Cancer?
Khalili, H., & Chan, A. T. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2175-7 · Cited by 10
Yen, S.-M., Kung, P., & Tsai, W. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-240 · Cited by 10
Preexisting Diabetes and Risks of Morbidity and Mortality After Gastrectomy for Gastric Cancer
Tsai, M., Wang, Y.-C., Kao, Y. H., Jeng, L., & Kao, C. (2015) · Medicine · doi:10.1097/md.0000000000001467 · Cited by 10
Chen, K., Chung, C., Hsu, W., Huang, T., Lin, C., Lee, T., Weng, M., Chiu, C., Chang, L., & Chiu, H. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14070 · Cited by 10
Maskarinec, G., Sadakane, A., Sugiyama, H., Brenner, A. V., Tatsukawa, Y., & Grant, E. J. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.04.009 · Cited by 10
Djebli, N., Parrott, N. J., Jaminion, F., O’Jeanson, A., Guerini, E., & Carlile, D. J. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13091 · Cited by 10
Takeishi, S., Mori, A., Fushimi, N., Hachiya, H., Yumura, T., Ito, S., Shibuya, T., Ohashi, N., & Kawai, H. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12409 · Cited by 10
Biobanks for Cardiovascular Epidemiology and Prevention
Iacoviello, L., Curtis, A. D., Donati, M. B., & de Gaetano, G. (2014) · Future Cardiology · doi:10.2217/fca.13.110 · Cited by 10
Kim, H. Y., Lee, H. A., Radu, P., & Dufour, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-65127-9 · Cited by 9
Nawata, K., & Kawabuchi, K. (2015) · Health · doi:10.4236/health.2015.72030 · Cited by 9
Kidney Cancer Screening and Epidemiology
Rossi, S. H., Tanaka, H., Usher‐Smith, J. A., Bernhard, J., Fujii, Y., & Stewart, G. D. (2022) · Société Internationale d’Urologie Journal · doi:10.48083/xbcx3386 · Cited by 9
Evaluation of prevalent and incident ovarian cancer co-morbidity
Stålberg, K., Svensson, T., Granath, F., Kieler, H., Tholander, B., & Lönn, S. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.164 · Cited by 9
Associations of GSTM1 and GSTT1 polymorphisms with pancreatic cancer risk
Fan, Y., Zhang, W., Shi, C., & Cai, D. (2012) · Tumor Biology · doi:10.1007/s13277-012-0598-6 · Cited by 9
Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry
Iwase, M., Fujii, H., Idewaki, Y., Nakamura, U., Ohkuma, T., Ide, H., Komorita, Y., Jodai, T., Yoshinari, M., & Kitazono, T. (2019) · Diabetology International · doi:10.1007/s13340-019-00390-0 · Cited by 9
Increased cancer mortality among Japanese individuals with hyperinsulinemia
Kira, S., Ito, C., Fujikawa, R., & Misumi, M. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100048 · Cited by 9
Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer
Singh, S. K., Apata, T., Singh, S., McFadden, M., & Singh, R. (2021) · Biomedicines · doi:10.3390/biomedicines9081020 · Cited by 9
Diabetes Mellitus as Cancer Risk: A 14-year, Cross-Sectional Analysis
Saewai, C., Fumaneeshoat, O., Thongsuksai, P., & Ingviya, T. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2205054 · Cited by 9
Isolation and Identification of a Novel Aromatic Amine Mutagen Produced by the Maillard Reaction
Nishigaki, R., Watanabe, T., Kajimoto, T., Tada, A., Takamura‐Enya, T., Enomoto, S., Nukaya, H., Terao, Y., Muroyama, A., Ozeki, M., et al. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900119j · Cited by 9
Age- and Sex-Specific Risks of Colorectal Cancers in Diabetic Patients
Chen, H.-F., Chen, P., Su, Y.-H., Su, H.-F., & Li, C. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.226.259 · Cited by 9
Yen, S.-M., Kung, P., & Tsai, W. (2014) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.10.040 · Cited by 9
Type 2 Diabetes does not worsen prognosis in hepatocellular carcinoma
Howell, J. A., Yiu, M., Gibson, R. N., Thomson, B., Stella, D. L., Gorelik, A., Prichard, P. J., & Nicoll, A. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2010.11.002 · Cited by 9
Koebnick, C., Smith, N., Huang, K., Martinez, M. P., Clancy, H., Williams, A. E., & Kushi, L. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-15 · Cited by 10
The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women
Li, Y., HENDRYX, M. S., Xun, P., He, K., Shadyab, A. H., Pan, K., Qi, L., & Luo, J. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01294-0 · Cited by 9
Assessment of glycemic susceptibility across multiple urological and reproductive disorders
Zeng, X., Li, Z., Lin, L., & Wei, X. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01404-x · Cited by 8
Risk-stratified screening for the early detection of kidney cancer
Rossi, S. H., Harrison, H., Usher‐Smith, J. A., & Stewart, G. D. (2023) · The Surgeon · doi:10.1016/j.surge.2023.10.010 · Cited by 8
Wang, C.-S., Chang, T., Yao, W. J., Wang, S.-T., & Chou, P. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01337.x · Cited by 8
Kobayashi, H., Takahashi, M., Fukutomi, M., Oba, Y., Funayama, H., & Kario, K. (2021) · Heart and Vessels · doi:10.1007/s00380-021-01815-0 · Cited by 8
Comprehensive transcriptome analysis of colorectal cancer risk of hyperglycemia in humans
Feng, W., Guo, H., Gong, H., Xue, T., Wang, X., Tang, C., Xu, Y., Dai, C., Bao, Y., Zhang, T., et al. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-587 · Cited by 7
Repression of the Notch pathway prevents liver damage in streptozotocin-induced diabetic mice
Açıkgöz, E., Aktuğ, H., Yiğittürk, G., Demir, K., Güven, Ü., Düzağaç, F., Oltulu, F., Yavaşoğlu, A., & Öktem, G. (2017) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2017.0014 · Cited by 8
Diabetes and kidney cancer risk among post-menopausal women: The Iowa women’s health study
Wang, S., Galbo, M. D. L., Blair, C. K., Thyagarajan, B., Anderson, K. E., Lazovich, D., & Prizment, A. E. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.07.010 · Cited by 8
Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma
Taura, N., Ichikawa, T., Miyaaki, H., Yatsuhashi, H., Ishibashi, H., & Nakao, K. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.167 · Cited by 8
Cuomo, G., Iannone, F. P., Lorenzo, A. D., Testa, C., Ciccarelli, M., Venturini, E., Cesaro, A., Pacileo, M., Tagliamonte, E., D’Andrea, A., et al. (2023) · Clinics and Practice · doi:10.3390/clinpract13020035 · Cited by 8
Cho, I. R., Yi, S., Choi, J. S., & Yi, J. (2022) · Cancers · doi:10.3390/cancers14071709 · Cited by 10
Impact of Diabetes on Patient Outcomes in Breast Cancer Patients
Tobe, A., Horimoto, Y., Kobayashi, K., KAMISADA, N., & HIRANO, M. (2022) · Breast Care · doi:10.1159/000524513 · Cited by 7
Chan, R. N. C., Lee, T. T. L., Chou, O. H. I., So, J., Chung, C. T., Dee, E. C., Ng, K., Tang, P., Roever, L., Liu, T., et al. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac138 · Cited by 7
Metadata
- Authors
- Inoue, M.
- Affiliations
- National Cancer Centre Japan (JP)
- Corresponding author
- Inoue, Manami
- ORCID
- Inoue, Manami
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-09-25
- Volume
- 166
- Issue
- 17
- Pages
- 1871
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2096623507
- Cited by
- 561
- References
- 59
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 20 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 28 · 2019: 29 · 2018: 22 · 2017: 35 · 2016: 22 · 2015: 31 · 2014: 41 · 2013: 51 · 2012: 55
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- diabetes mellitus, cancer risk, cancer incidence, liver cancer, pancreatic cancer, kidney cancer, colon cancer, gastric cancer, sex differences, Japan Public Health Center-based Prospective Study, Japanese adults, prospective cohort, hazard ratio, cancer mortality, cancer prevention, lifestyle modification, cancer survivorship, cancer survivorship support services
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Digestive System Neoplasms, Female, Humans, Japan, Male, Middle Aged, Neoplasms, Prospective Studies, Risk Factors, Incidence, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review